(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...
Amana Care Clinic – Muscatine has expanded its telehealth platform to provide remote medical consultations for patients throughout Muscatine and surrounding Iowa communities. The enhanced service ...
Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV® (enfortumab vedotin ...
During Self Care Week, running until November 23, the NHS is encouraging people to manage minor conditions like colds, sore throats, and upset stomachs at home. A well-stocked medicine cabinet can ...
Talking With Docs on MSN
Urinary retention management: identifying causes and treatment options for bladder emptying
15 immigrants released from custody after Idaho raid. What the judge said Bipartisan push to reform censure process emerges ...
Doctor warns that winter's deceptive comfort can lead to dehydration, silently increasing the risk of painful kidney stones.
Patients with upper tract urothelial carcinoma (UTUC) and urinary tract stone history are a high-risk subgroup requiring greater surveillance.
A trial evaluated whether rituximab can attain remission in adults with frequently relapsing nephrotic syndrome (FRNS) or steroid dependent nephrotic syndrome (SDNS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback